Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis.

Therefore, our data emphasize that GBM heterogeneity is a highly significant aspect to be considered in therapy, and that current GBM classification is of critical importance to establish personalized approaches.

also in 132,142 other papers